vs

Side-by-side financial comparison of BEASLEY BROADCAST GROUP INC (BBGI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $53.1M, roughly 1.1× BEASLEY BROADCAST GROUP INC). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -83.0% vs -358.4%, a 275.5% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -21.2%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -1.2%).

Beasley Broadcast Group, Inc., based in Naples, Florida, is an owner/operator of radio stations in the United States. As of September 2025, the company owns 54 stations under the Beasley Media Group name.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

BBGI vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.1× larger
RYTM
$57.3M
$53.1M
BBGI
Growing faster (revenue YoY)
RYTM
RYTM
+58.0% gap
RYTM
36.9%
-21.2%
BBGI
Higher net margin
RYTM
RYTM
275.5% more per $
RYTM
-83.0%
-358.4%
BBGI
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
-1.2%
BBGI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BBGI
BBGI
RYTM
RYTM
Revenue
$53.1M
$57.3M
Net Profit
$-190.1M
$-47.5M
Gross Margin
91.6%
Operating Margin
-433.6%
-82.2%
Net Margin
-358.4%
-83.0%
Revenue YoY
-21.2%
36.9%
Net Profit YoY
-9136.7%
-9.6%
EPS (diluted)
$-105.71
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BBGI
BBGI
RYTM
RYTM
Q4 25
$53.1M
$57.3M
Q3 25
$51.0M
$51.3M
Q2 25
$53.0M
$48.5M
Q1 25
$48.9M
$32.7M
Q4 24
$67.3M
$41.8M
Q3 24
$58.2M
$33.3M
Q2 24
$60.4M
$29.1M
Q1 24
$54.4M
$26.0M
Net Profit
BBGI
BBGI
RYTM
RYTM
Q4 25
$-190.1M
$-47.5M
Q3 25
$-3.6M
$-52.9M
Q2 25
$-154.2K
$-46.6M
Q1 25
$-2.7M
$-49.5M
Q4 24
$-2.1M
$-43.3M
Q3 24
$-3.6M
$-43.6M
Q2 24
$-276.0K
$-32.3M
Q1 24
$8.0K
$-141.4M
Gross Margin
BBGI
BBGI
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
BBGI
BBGI
RYTM
RYTM
Q4 25
-433.6%
-82.2%
Q3 25
-1.1%
-102.6%
Q2 25
5.5%
-93.4%
Q1 25
-4.1%
-143.7%
Q4 24
11.3%
-98.6%
Q3 24
2.1%
-132.0%
Q2 24
8.9%
-139.2%
Q1 24
-2.0%
-538.7%
Net Margin
BBGI
BBGI
RYTM
RYTM
Q4 25
-358.4%
-83.0%
Q3 25
-7.0%
-103.1%
Q2 25
-0.3%
-96.1%
Q1 25
-5.5%
-151.4%
Q4 24
-3.1%
-103.6%
Q3 24
-6.1%
-131.2%
Q2 24
-0.5%
-110.9%
Q1 24
0.0%
-544.4%
EPS (diluted)
BBGI
BBGI
RYTM
RYTM
Q4 25
$-105.71
$-0.73
Q3 25
$-1.97
$-0.82
Q2 25
$-0.09
$-0.75
Q1 25
$-1.50
$-0.81
Q4 24
$-1.23
$-0.71
Q3 24
$-2.33
$-0.73
Q2 24
$-0.18
$-0.55
Q1 24
$0.01
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BBGI
BBGI
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$9.9M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$-49.3M
$139.1M
Total Assets
$299.3M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BBGI
BBGI
RYTM
RYTM
Q4 25
$9.9M
$388.9M
Q3 25
$14.3M
$416.1M
Q2 25
$13.7M
$291.0M
Q1 25
$12.2M
$314.5M
Q4 24
$13.8M
$320.6M
Q3 24
$27.8M
$298.4M
Q2 24
$33.3M
$319.1M
Q1 24
$27.8M
$201.2M
Total Debt
BBGI
BBGI
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$247.1M
Q3 24
$265.2M
Q2 24
$264.9M
Q1 24
$264.5M
Stockholders' Equity
BBGI
BBGI
RYTM
RYTM
Q4 25
$-49.3M
$139.1M
Q3 25
$141.0M
$148.8M
Q2 25
$144.5M
$-11.9M
Q1 25
$144.6M
$18.9M
Q4 24
$147.2M
$21.7M
Q3 24
$145.8M
$11.2M
Q2 24
$149.1M
$39.3M
Q1 24
$149.1M
$61.6M
Total Assets
BBGI
BBGI
RYTM
RYTM
Q4 25
$299.3M
$480.2M
Q3 25
$534.6M
$506.9M
Q2 25
$548.0M
$372.7M
Q1 25
$539.3M
$386.7M
Q4 24
$549.2M
$392.3M
Q3 24
$571.5M
$363.6M
Q2 24
$573.2M
$381.8M
Q1 24
$566.3M
$258.7M
Debt / Equity
BBGI
BBGI
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.68×
Q3 24
1.82×
Q2 24
1.78×
Q1 24
1.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BBGI
BBGI
RYTM
RYTM
Operating Cash FlowLast quarter
$-3.2M
$-25.4M
Free Cash FlowOCF − Capex
$-4.4M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BBGI
BBGI
RYTM
RYTM
Q4 25
$-3.2M
$-25.4M
Q3 25
$-4.9M
$-26.6M
Q2 25
$3.1M
$-23.3M
Q1 25
$-3.5M
$-40.4M
Q4 24
$-1.5M
$-18.8M
Q3 24
$-4.8M
$-25.2M
Q2 24
$6.6M
$-29.1M
Q1 24
$-4.0M
$-40.7M
Free Cash Flow
BBGI
BBGI
RYTM
RYTM
Q4 25
$-4.4M
Q3 25
$-7.1M
Q2 25
$2.5M
Q1 25
$-4.3M
Q4 24
$-1.9M
Q3 24
$-5.4M
Q2 24
$5.6M
Q1 24
$-5.0M
FCF Margin
BBGI
BBGI
RYTM
RYTM
Q4 25
-8.3%
Q3 25
-14.0%
Q2 25
4.7%
Q1 25
-8.7%
Q4 24
-2.8%
Q3 24
-9.3%
Q2 24
9.2%
Q1 24
-9.2%
Capex Intensity
BBGI
BBGI
RYTM
RYTM
Q4 25
2.3%
Q3 25
4.4%
Q2 25
1.1%
Q1 25
1.6%
Q4 24
0.6%
Q3 24
1.1%
Q2 24
1.7%
Q1 24
1.7%
Cash Conversion
BBGI
BBGI
RYTM
RYTM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-506.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BBGI
BBGI

Audio Advertising$40.5M76%
Digital Advertising$12.6M24%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons